Core Points - PharmaCorp RX Inc. has agreed to acquire a 100% interest in a PharmaChoice Canada bannered pharmacy business for a purchase price of $2,400,000, expected to close around July 31, 2025 [1][2] - The acquisition will be funded using cash on hand and is subject to customary adjustments and a net asset value adjustment as of the closing date [1] - The company currently operates three PharmaChoice bannered pharmacies and plans to continue acquiring more as part of its strategic alliance with PharmaChoice Canada [2] Company Strategy - The acquisition reflects PharmaCorp's strategic alliance with PharmaChoice Canada and its disciplined acquisition strategy [2] - The company sees strong opportunities for growth and intends to remain active in pursuing further acquisitions in the coming months [2] - PharmaCorp will also consider acquiring independently owned non-PharmaChoice Canada bannered pharmacies and operate them under the PharmaChoice Canada banner [2]

Market Position and Growth - Guardian Pharmacy Services is a market leader in the Assisted Living Facility (ALF) market with a 13% market share[12] - The company serves over 189,000 residents[12] - The company has 32 pharmacies with > 40% Market Share[16] - The company has 12 pharmacies as Market Share Leader[16] - The company has 11 states with > 25% Market Share[15] - The company's revenue has grown at a CAGR of 15.8% from 2012 to 2024[19] Financial Performance - Adjusted EBITDA in 2024 was $90.834 million[60] - The company's Insurance Optimizer program resulted in ~$41 million in savings, or ~$514 per resident, for ~79,000 residents with claims[52] Acquisition Strategy - The company targets acquisitions with ~$10 - $30 million in revenue and ~2,000 - 3,500 residents[23] - Acquired pharmacies demonstrate strong revenue and resident growth after integration with Guardian[30]

Core Insights - PharmaCorp Rx Inc. reported a net income of $254,000 for Q1 2025, marking its first quarter of positive net income [2][3] - The company has entered into non-binding letters of intent to acquire four community pharmacies for approximately $12.5 million, aligning with its acquisition-driven growth strategy [5][6] Financial Performance - Same-store sales increased by 4.0% year-over-year compared to Q1 2024, indicating organic growth across the pharmacy network [3] - Total prescription volumes rose by 3.2% year-over-year, reflecting sustained patient engagement [4] Acquisition Strategy - The proposed acquisitions are expected to be accretive to earnings and will be funded through a combination of cash and common shares [5][6] - The completion of these acquisitions is subject to the execution of definitive agreements and customary conditions, with anticipated closings between June 30 and August 31, 2025 [7] Operational Outlook - The company remains committed to expanding its national footprint through strategic acquisitions and operational excellence [9] - Management expresses confidence that the momentum from Q1 results will continue to build in future quarters [3][9]

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was reported at $329 million, reflecting a 20% year-on-year increase [5][12] - Resident count increased by 15% year-on-year, reaching approximately 189,000 [5][12] - Adjusted EBITDA for the quarter was $23.4 million, a 16% increase compared to the previous year [5][12] - Excluding PUBCO costs, adjusted EBITDA growth was 20% year-on-year [12] Business Line Data and Key Metrics Changes - The growth in revenue was driven by organic growth and acquisitions, specifically from Heartland and Freedom pharmacies [12] - Gross profit increased to $64.4 million, representing a 17% increase [12] Market Data and Key Metrics Changes - The company is actively monitoring industry trends, particularly the impact of tariffs and the Inflation Reduction Act [9][10][11] Company Strategy and Development Direction - The company is focused on sustainable long-term value creation for shareholders and is committed to integrating multiple acquisitions [5][6] - An acquisition of a small pharmacy in Wichita, Kansas was completed, increasing the total number of pharmacies to 52 [6] - The company is expanding its regional presence through Greenfield startups and acquisitions [8][20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating potential impacts from the Inflation Reduction Act and tariffs, indicating a robust acquisition pipeline [10][11][38] - The company expects to end the year in the upper half of its revenue guidance range due to strong Q1 performance [5][15] Other Important Information - The company ended Q1 with $14 million in cash and zero debt, maintaining a strong financial position [15] - The integration of Heartland's IT infrastructure is underway, which may impact profitability in the short term but is expected to enhance long-term success [13][14] Q&A Session Summary Question: Size of Heartland drag in Q1 and full year integration costs - Management indicated that the integration costs were included in guidance, with approximately $500,000 pulled into Q1 due to expedited operating system conversion [25] Question: Impact of the Trump executive order on payer negotiations - Management noted uncertainty regarding the executive order's effects but remains positive about ongoing discussions with payors [26][27] Question: Breakdown of resident count growth between same-store metrics and acquisitions - Management confirmed that organic growth met guidance, with the remainder attributed to acquisitions [36] Question: Pipeline status and impact of economic uncertainty - Management reported a robust acquisition pipeline, indicating that economic pressures have not negatively impacted opportunities [38]

That's up from 4,300 in October 2023 and 4,800 in February. During that month, these centers handled 40% of the prescription volume on average at supported pharmacies, which translates to roughly 16 million prescriptions filled per month at the different sites, the company said. "Right now, they're the backbone to really help us offset some of the workload in our stores, to obviously allow more time for our pharmacists and technicians to spend time with patients," Rick Gates, Walgreens' chief pharmacy offic ...

Core Insights - PharmaCorp RX Inc. has successfully completed the acquisition of a pre-1954 charter company in Ontario, allowing it to operate pharmacies in the region [1][2] - The acquisition is significant as it enables PharmaCorp to bypass ownership restrictions under the Drug and Pharmacies Regulations Act (Ontario), which limits non-pharmacist owned corporations from operating pharmacies [2] - PharmaCorp currently operates three PharmaChoice bannered pharmacies and plans to continue acquiring more pharmacies under the PharmaChoice Canada brand [3] Company Overview - PharmaCorp operates under the TSX Venture Exchange with the symbol PCRX and is focused on expanding its pharmacy operations in Canada [3] - The company aims to acquire both PharmaChoice Canada branded pharmacies and independently owned non-PharmaChoice Canada bannered pharmacies, integrating them into its operations [3]

Group 1 - PharmaCorp Rx Inc. has filed its audited financial statements and associated MD&A for the year ended December 31, 2024, on SEDAR+ [1] - The company operates three PharmaChoice bannered pharmacies in Canada and plans to acquire more as they become available [2] - PharmaCorp intends to acquire independently owned non-PharmaChoice Canada bannered pharmacies and operate them under the PharmaChoice Canada banner [2] Group 2 - PharmaCorp shares are traded on the TSX Venture Exchange under the symbol PCRX [2]

"Pharmacies have a legal responsibility to prescribe controlled substances in a safe and professional manner, not dispense dangerous drugs just for profit," Attorney General Pamela Bondi said in a statement. "This Department of Justice is committed to ending the opioid crisis and holding bad actors accountable for their failure to protect patients from addiction." WALGREENS SUED BY DOJ, ALLEGING IT KNOWINGLY FILLED ILLEGAL PRESCRIPTIONS INCLUDING 'DANGEROUS' OPIOIDS Walgreens has agreed to pay up to $350 mi ...

近年，药店发生的变化比过去十几年都要多，尤其是人工智能（AI）介入，让这个原本以"开门等客"为 主的行业有了更多可能。一位连锁药店从业人员告诉笔者，他以前总觉得药店竞争无非是"价格战""服 务战"，但现在真正决定胜负的可能是"谁的数据跑得更快？谁的AI系统更聪明？" 动态管理 药店借助AI提升实力，不是简单地摆几台智能设备，或者上线购药平台。关键在于，将AI技术融入经 营，让其成为提高效率、扩大市场的核心驱动力。 一是智能管理库存。很多药店的资金都压在库存里，要么某些药品囤积过多，占用资金，要么热门药品 断货，导致客户流失。AI系统可以分析历史销售数据、市场趋势，甚至社交媒体的健康话题热度，预 测药品需求变化，提前向店长预警，提醒补货。 这几年，笔者逛药店，感觉变化很大，尤其是一些使用AI技术的药店，顾客体验和传统药店完全不在 一个层次。以前，顾客进药店，十有八九是面对一排货架，自己看标签找药，或者让店员推荐，但很多 时候，店员的推荐不太专业，尤其是一些年轻的营业员，可能连药品的主要成份和适应症都说不清楚， 只会推销利润高的产品。这种情况下，买药多少带点碰运气的意味。 但在使用了AI的药店，就能直观地感觉到效 ...

平均一天要倒闭 274 家 2024 年 11 月的一个午后，王宁脚步匆匆，正赶往医院。路过街角一家药店时，他眼角余光瞥见玻璃 门上贴着一张 A4 纸，纸张褶皱，上面字迹歪扭，写着 "店长调货去了，马上就回" 。 王宁下意识地透过玻璃朝店内张望，这一望，心里满是诧异。货架上空空荡荡，厚厚的灰尘在阳光的 直射下无所遁形，怎么看都不像是马上要营业的样子，倒像关门许久了。他向路过的居民打听："这 家店开了不到一年吧？" 对方笑着回他："半年都撑不到。" 药店倒闭并非个例。社交平台上，有不少相关的帖子，有人称："药店突然倒闭，你们现在都在干什 么？" 一位药店工作人员回复："我们晚上正上班呢，老板突然进来，说不干了，大家立刻打包，一 会儿就把东西搬空了。" 发帖人也分享自身经历："今天还在上班，明天店就撤了。" 曾几何时，街角的药店仿佛一夜之间成了城市的主角，像雨后春笋般疯狂生长。处方药柜里的高毛利 商品，撑起了一个个财富神话。百米长的街道上，四五家药店比邻而居，仿佛在比拼谁更能吸引顾客 的目光。那时的场景，荒诞却真实，资本在这片小小的战场上狂欢，药店成了这场盛宴的主角。 然而，时过境迁，如今推开那些贴着"旺铺转租" ...